| Literature DB >> 27431268 |
Atmika Paudel1, Hiroshi Hamamoto, Suresh Panthee, Kazuhisa Sekimizu.
Abstract
The current trend of increasing infections by multidrug-resistant pathogens requires the discovery of novel antimicrobial agents with new target and selective toxicity towards pathogens. Menaquinone is a component of electron transport chains in a majority of anaerobic bacteria and Gram-positive bacteria. Due to its exclusivity in bacteria, menaquinone is thought to be a potential target for development of therapeutically effective antibacterial agents without side effects. In this review, we summarize inhibitors of menaquinone biosynthesis and antibiotics directly targeting menaquinone in bacteria.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27431268 DOI: 10.5582/ddt.2016.01041
Source DB: PubMed Journal: Drug Discov Ther ISSN: 1881-7831